This module is designed for you to apply the knowledge gained from Immune Checkpoint Inhibitors & Respiratory Toxicities: Key Points for the Community Pharmacist through the review of case-based scenarios.
At the completion of this application-based activity, the participant will be able to:
- Recognize the presenting symptoms of the most common respiratory immune-related adverse events in patients treated with immune checkpoint inhibitors.
- Identify levels of severity of respiratory immune-related adverse events and appropriate treatment.
Activity Type: Application-based
Target Audience: Pharmacists
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following activity is not approved for CPE credit.
To complete Hiding in Plain Sight: Respiratory Toxicities, participants will need to complete the activity and evaluation questions. Participants need to have a valid pharmacist.com username and password.
Hiding in Plain Sight: Respiratory Toxicities is a home-study continuing education activity for pharmacists developed by the American Pharmacists Association with support from Merck & Co., Inc. © 2020 American Pharmacists Association
Dan Zlott, PharmD, BCOP and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete staff disclosures, please see the Education and Accreditation Information section at www.pharmacist.com/apha-disclosures.
There is no fee associated with this activity.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.